Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
clinical trials
2
×
eli lilly
life sciences
national blog main
2
×
san francisco blog main
alexion pharmaceuticals
alnylam pharmaceutials
arrowhead pharmaceuticals
black diamond therapeutics
bladder cancer
blueprint medicines
boehringer ingelheim
boston
cancer
cancer drugs
deals
deciphera pharmaceuticals
dicerna pharmaceuticals
endometral cancer
europe blog main
european society for medical oncology
fda
glioblastoma
hepatitis b
indiana blog main
indiana top stories
johnson & johnson
loxo oncology
mirati therapeutics
national top stories
neurodegenerative diseases
new enterprise associates
primary hyperoxaluria
rna interference
san francisco top stories
turning point therapeutics
wisconsin blog main
What
companies
2
×
medicines
2
×
abandoning
ago
baggage
biotech
black
cancer
clinic
cuts
deal
development
diamond
dicerna
drug
eluded
free
gets
hopes
interference
ipo
lead
leading
lines
long
molecular
nears
new
pharma
phase
ready
research
rna
rnai
signs
small
targets
therapeutics
wasn’t
Language
unset
Current search:
medicines
×
biotech
×
" national blog main "
×
companies
×
" clinical trials "
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
